Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_assertion type Assertion NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_head.
- NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_assertion description "[The key findings of this study are the increased expression of CYP1B1 in the majority of ovarian cancers investigated (92%), with a strong correlation demonstrated between CYP1B1 expression in both primary and metastatic ovarian cancer (P = 0.005 Spearman's rank correlation test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_provenance.
- NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_assertion evidence source_evidence_literature NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_provenance.
- NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_assertion SIO_000772 11461084 NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_provenance.
- NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_assertion wasDerivedFrom befree-20140225 NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_provenance.
- NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_assertion wasGeneratedBy ECO_0000203 NP447471.RAF1lYM60VK7boKKb9iG_YYcobm0Pj8o70Wx8AjOH-kJk130_provenance.